NCT03034317View on ClinicalTrials.gov

NeuRx Diaphram Pacing System (DPS) Use in Amyotrophic Lateral Sclerosis (ALS)

NAWithdrawnINTERVENTIONAL

0

Timeline

Start Date

February 2, 2017

Primary Completion Date

February 8, 2018

Study Completion Date

February 12, 2018

Conditions

Amyotrophic Lateral Sclerosis

Interventions

DEVICE

NeuRx DPS

Patients who are diagnosed with ALS, have initiated NIV and choose to have the NeuRx DPS implanted.

Sponsors

Lead Sponsor

Synapse Biomedical

All Listed Sponsors

lead

Synapse Biomedical

INDUSTRY

NCT03034317 - NeuRx Diaphram Pacing System (DPS) Use in Amyotrophic Lateral Sclerosis (ALS) | Biotech Hunter | Biotech Hunter